Purpose. Bloodstream infections are major causes of morbidity and mortality among hospitalized patients worldwide. Early identification of micro-organisms from blood culture can facilitate earlier optimization of treatment. The objective of this study was to assess an in-house method based on a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) platform (Clin-TOF MS) for direct organism identification.
INTRODUCTION
Bloodstream infections (BSIs) are major causes of morbidity and mortality among hospitalized patients worldwide. Timely and accurate detection and identification of the infecting micro-organisms are essential, with an average increase in mortality of nearly 8 % for every hour of delay to the administration of appropriate antimicrobial therapy to patients [1] . Although patients with suspected BSIs are usually treated empirically with broad-spectrum antimicrobial agents [2] , these are not always the most appropriate therapy. Furthermore, approximately 20 % of patients with BSIs are initially assigned inappropriate antimicrobials, leading to increased length of hospitalization and 30-day mortality rates [3] . Microbiological identification is of the utmost important for infected patients, and early organism detection from blood cultures (BCs) and rational use of antimicrobials can facilitate earlier optimization of treatment [4] .
Great effort has been put into the development of cultureindependent BC diagnostic methods, such as BC-GN/GP DNA chips and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), with the aim of identifying micro-organisms from blood samples more rapidly [5, 6] Among the different methods, MALDI-TOF MS is a powerful tool in microbiological diagnosis [7, 8] with short turnaround times, broad species coverage, high throughput and low cost. Several direct culture methods have been reported that allow successful identification of pathogens to genus or species level using MALDI-TOF-MS, including Sepsityper processing (Bruker Daltonics, Billerica, MA, USA) [9] , the centrifugation method [10] and the lysis filtration method [11, 12] . To date, selected types of BC vials, including BD BACTEC's Plus Aerobic/F (PAF), Lytic Anaerobic/F (LAF) and Peds Plus/F (PPF), and bio-M erieux's BacT/Alert FAN Aerobic (FA), Anaerobic Plus (FN), Standard Anaerobic (SN), Standard Aerobic (SA) and Pediatric FAN (PF), have been used for the MALDI-TOF identification [13] . However, the reliability of MALDI-TOF MS in the direct identification of micro-organisms from positive BCs is influenced by the detection methods used, the species of micro-organisms involved and the types of culture vials used [12] . Generally speaking, Gram-negative bacteria are easier to identify than Gram-positive bacteria. There have been significant differences in the detection of bacteria for different vial types. The accuracy of direct identification by MALDI-TOF MS has been lower when charcoal-containing BacT/Alert FA (bioM erieux) vials are used compared to other types of vials [14] .
The aim of the present study was to evaluate an in-house rapid MALDI-TOF MS-based direct diagnostic method. We introduced a new MALDI-TOF MS -Clin-TOF MS (Bioyong, Beijing, People's Republic of China) -for the detection of micro-organisms from positive BC vials from five different manufacturers and then evaluated its accuracy.
METHODS

Samples and study design
With the exception of the 10 polymicrobial samples, a total of 666 BC vials with a single micro-organism that the instruments had signalled positive results for after no more than 3 days' incubation were selected for this study. In detail, 97 BACTEC PAV, 121 BACTEC LAV, 90 BacT/Alert SA, 197 BacT/Alert SN and 161 BacT/Alert FA were collected randomly between 7 August 2017 and 30 October 2017 from 5 academic hospitals, including the Second Affiliated Hospital of Zhejiang University; Taizhou Hospital of Zhejiang Province; Hangzhou Hospital of Zhejiang Provincial Corps, the Chinese People's Armed Police Forces; Zhejiang Provincial People's Hospital; Hangzhou First People's Hospital. PAV and LAV were incubated in BACTECFX (Becton Dickinson, Heidelberg, Germany), and SA, SN and FA were incubated in BacT/Alert 3D (bio-M erieux, Marcy l'Etoile, France). The BC vials had been incubated in each instrument from the five academic hospitals for no more than 3 days before they were flagged as positive and transferred to the study hospital in 2 h. The BCs were collected following standard procedures [15, 16] and subjected in parallel to the in-house rapid diagnostic method for direct identification by MALDI-TOF MS and the conventional sub-culture method as the reference identification method.
Reference identification from subcultures
At the time of BC positivity, aliquots were inoculated on Columbia blood agar. An additional anaerobic culture was performed with anaerobic bottles. Solid media were incubated at 37 C in 5 % CO 2 for 18-24 h, or even up to 5 days. Colonies were spotted onto a ground steel target in triplicate (Bioyong, Beijing, People's Republic of China). Each spot was overlaid with 1 µl of matrix solution (a-cyano-4-hydroxycinnamic acid in 50 % acetonitrile/0.1 % trifluoroacetic acid) and allowed to co-crystallize for 1 min at room temperature. The spectra were acquired using a Clin-TOF mass spectrometer in the linear positive mode (laser frequency, 20 Hz; acceleration voltage, 20 kV; pulse voltage, 1.9 kV; Einzel voltage, 5 kV; mass range, 2000-13000 Da). Escherichia coli ATCC8739 was used for the calibration of the instrument. The composite profile was analysed using BioExplorer V2.0 software (Bioyong). The identification score criteria used followed those recommended by the manufacturer: a score of 25.00 indicated reliable identification, while a score of <25.00 was interpreted as inconclusive and it was recommended that the sample be retested or that the test be supplemented to help identification. At the same time, colonies were analysed with Bruker MS as the reference method; if the results were different, 16S rRNA and ITS gene sequencing was acquired [17, 18] . The polymicrobial samples were excluded from further analysis.
Direct identification by MALDI-TOF MS
An improved in-house MALDI-TOF MS protocol for the direct identification of pathogens from BCs was according to the study of Ferroni et al. [19] . Micro-organisms from BC fluid were centrifuged following the in-house rapid method; details of the experimental procedures are shown in Fig. 1 . Then 30 l of 5 % saponin and 1 ml distilled water were used to destroy the cell composition in the BC fluid, after which the BC fluid was centrifuged at 50 g for 2 min to sediment the blood cells. The supernatant was transferred to another 1.5 ml EP tube and centrifuged at 16200 g for 1 min before being washed with 1 ml distilled water. The pellet was resuspended with 15 µl 70 % formic acid and mixed with 15 µl acetonitrile. After a final centrifugation, 1 µl aliquots of the supernatant were spotted onto the ground steel target in triplicate and analysed by the Clin-TOF mass spectrometer. Scores above 25.0, the cutoff value, were accepted as reliable identification.
Statistical analysis
Successful identification by the improved in-house rapid method was defined as achieving the same result as the reference identification method. In this study, we collected BCs using five different types of vials that are widely used globally and the 2 test was conducted to compare among the different types of bottles. All statistical calculations were performed using Statistical Package for the Social Sciences (SPSS) version 19.0 software (SPSS Inc., Chicago, IL, USA).
RESULTS
Identification from reference method through MALDI-TOF MS Six hundred and sixty-three aerobes and 3 anaerobes were identified in the 666 selected BC vials (Table 1 ). All were accurately identified by Clin-TOF compared with Bruker MS, giving an accuracy of 100 % (666/666). Among the aerobes, 446 Gram-negative bacteria, 207 Gram-positive bacteria and 10 yeasts were identified. Enterobacteriaceae and Staphylococcus spp. were the most common bacteria from BCs, comprising 197 Klebsiella pneumoniae, 128 E. coli, 63 Staphylococcus aureus and 83 Coagulase-negative staphylococci.
Accuracy rate of in-house method
The number accurate identifications achieved by the inhouse method was 590 (587 aerobes and 3 anaerobes) and the accuracy rate was 88.6 % (590/666), without misidentification. As shown in Table 1 , 93.3 % (416/446) of Gramnegative aerobes were identified accurately, with particularly high identification rates being achieved for K. pneumoniae (96. 4 %, 190/197 ) and E. coli (97.7 %, 125/128). It was noted that lower accuracy rates were achieved for several nonfermenting Gram-negative aerobes, such as Pseudomonas aeruginosa and Acinetobacter spp. Gram-positive aerobes appeared at a lower rate (81.6 %, 169/207) than Gramnegative aerobes, and a portion of coagulase-negative staphylococci had a particularly low accuracy rate, while several Streptococcus spp. had no identification results, except for Streptococcus agalactiae. The identification rate was the lowest for yeasts, at a mere 20 %. Overall, anaerobes had a 100 % (3/3) accuracy rate. (Table 2) . There was a significant difference (P=0.006) in the overall 
Comparison of accuracy rates among different types of vials
DISCUSSION
There are currently three major suppliers of MALDI-TOF MS instruments for clinical microbiology use in China, namely Bruker MS, Vitek MS and Clin-TOF MS . The identification mechanism for the Clin-TOF MS instruments is same as that for Bruker MS instruments; they operate by comparing the spectra based on proteins detected directly from intact micro-organisms with those from reference databases. The Clin-TOF MS BioExplorer V2.0 software database has been developed independently by Beijing Bioyong, and includes more than 370 genera, 2200 species and 7900 strains. Fan et al. evaluated the performance of Clin-TOF MS for Gram-negative bacteria identification, and found that 98.05 % (1005/1025) were correctly identified by Clin-TOF, while 99.22 % (1017/1025) were correctly identified by Bruker MS [20] . Ma et al. evaluated the performance on clinical common bacteria for a total of 1259 strains covering 134 species; 96.67 % were correctly identified, indicating that Clin-TOF MS is an effective tool for clinical micro-organism identification [21] .
Bruker MS is the most widely used equipment for the direct identification of micro-organisms from BC bottles, followed by Vitek MS. Our study is the first report to use the Clin-TOF MS with an in-house method. It showed excellent performance for the direct identification of pathogens from positive BC vials, with an accuracy rate of 88.6 % and no misidentification results. A rapid and accurate diagnosis can diminish the use of inadequate and broad-spectrum antibiotics, thereby improving prognosis and reducing the potential development of resistance and possible side-effects [19] . The in-house method showed acceptable performance, with its accuracy rate if 88.6 % (590/666), in comparison to previous reports detailing other methods, including Sepsityper processing (88.7 % accuracy) [6] , the centrifugation method (87 % accuracy) [10] , lysis filtration (85.5 % accuracy) [22] and separator tubes (78.1 % accuracy) [23] . The in-house method showed a great degree of agreement with the reference identification method from sub-cultures.
The species of bacteria from bloodstream infections were consistent with those isolated from other Chinese hospitals [24] . The successful identification rate for Gram-negative aerobes was 93.3 % from five types of BC vials, followed by Gram-positive aerobes at 81.6 %. Regardless of the type of BC vials, the identification accuracy for Gram-positive bacteria was generally lower than that for Gram-negative aerobes, possibly due to the thick peptidoglycan layer of the cell wall [12, 25] . Among the Gram-positive aerobes, Streptococcus spp. had the lowest success rate at 52.2 %. Specifically, four Streptococcus salivarius, four Streptococcus pneumoniae, two Streptococcus mitis and one Streptococcus anginosus were not identified. This is not surprising because there was a high similarity in the protein profiles between the S. pneumoniae and S. mitis groups [26] . Thus, it is advisable to report these as the S. pneumoniae/S. mitis group, pending additional identification tests. The lack of an appropriate database for the particular group of organisms might partially explain this fact, which also illustrates difficulties in the taxonomy. Our study had the limitation that the number of anaerobes was too small to represent the success rate (3/3) of rapid identification (although the possibility of anaerobes causing bacteraemia is relatively low). Three species of yeast in this study were commonly isolated from bloodstream infection, but the accuracy rate was too low, which showed that our in-house method requires further improvement.
The identification rate was 94.03 % (205 out of 218 samples) for the samples from BACTEC vials (PAF and LAF) and 85.94 % (385 out of 448) for the samples from the BacT/ Alertvials (SN, SA and FA). The differences between the two systems were statistically significant (P=0.006), which was in line with other reports. Romero-Gómez MP et al.
[27] showed a higher detection rate (76.19 %) in BACTEC vials than BacT/Alert (61.53 %), and the accurate identification rate for 107 monobacterial cultures and 6 polymicrobial cultures from BacT/Alert positive BCs was only 58 and 52 % for Gram-positive bacteria, and 82.5 and 90 % for Gramnegative bacilli with the MALDI Sepsityper kit and the saponin method, respectively [28] . Wüppenhorst N. et al.
[29] tried a new protocol to improve the identification rates for charcoal-containing BacT/Alert FA bottles, but even with a reduced cutoff value at 1.4 (Bruker MALDI-TOF MS), the rate was still only 77.8 % (n=212). In our study, 161 FA samples were included, and the accuracy rate was 82 %, which is higher than previously reported and shows that the in-house Clin-TOF MS method is reliable.
In a laboratory setting, this in-house Clin-TOF MS method is far more cost-effective, costing about $0.5 per sample compared to $7 for the Sepsityper kit [11] and $1.5 for another previously reported in-house protocol for direct Bruker MALDI-TOF MS [6] . Further, our protocol is more convenient and efficient, with a turnaround time of about 20 min, which is better than those for the Sepsityper kit and other in-house protocols [6, 11, 30] .
In conclusion, our study provides an effective sample preparation method for the direct identification of pathogens from positive BC vials using Clin-TOF MS. It is suitable for clinical laboratory use with positive BC samples from all types of BC vials and will help clinicians make precise diagnoses and provide targeted prescriptions, reducing the risk of the potential development of resistance.
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